DNDI-6148
DNDI-6148 is a novel preclinical candidate for the research of visceral leishmaniasis.
Product Specifications
CAS Number
2243909-59-1
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/dndi-6148.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(C)N(C2=NC=CC=C2)N=N1)NC3=CC=C4C(B(O)OC4)=C3
Molecular Formula
C16H14BN5O3
Molecular Weight
335.13
References & Citations
[1]Mowbray CE, et al. DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis. J Med Chem. 2021 Nov 11;64 (21) :16159-16176.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Leishmania
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP325651M 100 µg
Neuro D4 (DPF1) (NM_001135155) Human Recombinant Protein
Sign In for Pricing
View Details